MLKL and non-alcoholic fatty liver: Canonical RIP1-RIP3-MLKL-mediated necroptosis is implicated in multiple human diseases, including in the progression of non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) (1–3).